breast cancer

SABCS 2019 – Astrazeneca and Daiichi join the Her2 resistance
EP Vantage
Wed, 12/11/19 - 10:24 am
breast cancer
AstraZeneca
Daiichi Sankyo
SABCS
trastuzumab deruxtecan
After FDA rejection, Immunomedics tries again with breast cancer drug
Biopharma Dive
Tue, 12/3/19 - 10:23 pm
Immunomedics
breast cancer
sacituzumab govitecan
metastatic triple-negative breast cancer
FDA
Japan Approves Genetic Testing For Breast Cancer Treatment
Forbes
Sat, 11/30/19 - 10:58 pm
Japan
genetic testing
breast cancer
BRACAnalysis CDx
Myriad Genetics
diagnostics
PhoenixMD Adds Seed Funding to Test Experimental Breast Cancer Drug
Xconomy
Tue, 11/26/19 - 10:25 am
Phoenix Molecular Designs
breast cancer
PMD-026
clinical trials
Puma Biotechnology Has a Simple Plan to Get Back to Growth
Motley Fool
Mon, 11/18/19 - 10:21 am
Puma Biotechnology
Nerlynx
breast cancer
Here's Why Seattle Genetics Stock Jumped 25.7% in October
Motley Fool
Thu, 11/7/19 - 10:56 pm
Seattle Genetics
breast cancer
advanced breast cancer
clinical trials
tucatinib
Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates
Pharmaforum
Wed, 11/6/19 - 10:18 am
Daiichi Sankyo
Seattle Genetics
breast cancer
AstraZeneca
trastuzumab deruxtecan
Herceptin
Blood Test Can Detect Breast Cancer 5 Years Before Symptoms Occur
Medical Devices and Diagnostics Industry
Mon, 11/4/19 - 07:20 pm
breast cancer
diagnostics
tumor-associated antigens
MacroGenics' Metastatic Breast Cancer Drug Shows Survival Benefits in Phase III Trial
BioSpace
Wed, 10/23/19 - 02:59 pm
Macrogenics
metastatic HER2-positive breast cancer
margetuximab
breast cancer
clinical trials
AstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC
Fierce Biotech
Thu, 10/17/19 - 10:48 am
AstraZeneca
FDA
antibody-drug conjugate
trastuzumab deruxtecan
breast cancer
It May Be Time For Standard Breast Cancer Treatment To Change
Forbes
Sun, 10/6/19 - 12:44 pm
breast cancer
HER2-negative breast cancer
Novartis
ribociclib
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
Xconomy
Tue, 10/1/19 - 10:29 am
ESMO
PARP inhibitors
prostate cancer
KRAS
Seattle Genetics
AstraZeneca
Merck
GSK
Amgen
breast cancer
Roche
Pfizer
This Bristol-Partnered Biotech Stock Just Fumbled On A Cancer Study
Investors Business Daily
Thu, 09/26/19 - 07:39 pm
Bristol-Myers Squibb
Nektar Therapeutics
breast cancer
clinical trials
NKTR-214
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
RAPS.org
Sun, 09/15/19 - 09:47 pm
breast cancer
FDA
Ibrance
Kisqali
Verzenio
Pfizer
Novartis
Eli Lilly
Hormone therapy during menopause raises breast cancer risk for years, study finds
Stat
Thu, 08/29/19 - 08:12 pm
HRT
breast cancer
Novartis' Kisqali sharpens survival edge with second ph3 win
Fierce Pharma
Thu, 08/1/19 - 12:00 am
Novartis
Kisqali
breast cancer
clinical trials
Did cancer clinical trials stay on track at ASCO 2019?
Pharmaforum
Fri, 07/19/19 - 01:00 pm
ASCO
clinical trials
cancer
ASCO 2019
bladder cancer
breast cancer
prostate cancer
pancreatic cancer
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
Xconomy
Wed, 06/5/19 - 10:43 am
ASCO 2019
cancer
immunotherapy
diagnostics
Veracyte
Grail
Moderna Therapeutics
Amgen
Nektar Therapeutics
Blueprint Medicines
Merck
AstraZeneca
Roche
breast cancer
ASCO: Novartis' Kisqali posts first-in-class survival win in younger women
Fierce Pharma
Sat, 06/1/19 - 12:45 pm
breast cancer
ASCO 2019
Novartis
clinical trials
Kisqali
Breast cancer survival data buoys Macrogenics and Puma
Biopharma Dive
Thu, 05/16/19 - 11:28 pm
Macrogenics
margetuximab
Puma Biotechnology
Nerlynx
breast cancer
ASCO 2019

Pages